Steve Andrzejewski is the CEO of Spiritus Pharmaceuticals, a new company focused on respiratory medicines. Prior to Spiritus, he served as the CEO of Nycomed, Inc., a dermatology company in the US with revenues of $400 million and 700 employees. Steve’s experience in pharmaceuticals spans 25 years including roles as Chief Commercial Officer at Nycomed from King Pharmaceuticals, Senior Vice President of Commercial Business at Endo Pharmaceuticals, and numerous roles at Schering-Plough where he started in the Management Associate program as a sales representative and worked his way up to a number of Vice President positions. Mr. Andrzejewski is credited for his work in launching and building the Claritin brand and its DTC advertising. He holds a Bachelor’s degree in Psychology from Hamilton College in NY, and a MBA in Finance/International Business from New York University. He also serves the Boards of Duke University’s Fuqua Health Care Advisory Council and Health eVillages, an international program residing within the Robert F. Kennedy Center for Justice & Human Rights with a focus on helping third world countries address healthcare issues via the use of handheld mobile devices.
Mr. Andrzejewski was named one of the Most Influential DTC People by Medical, Marketing & Media in 2007, one The 50 Most Powerful People in Marketing by Advertising Age in 2001, and one of the 21 People to Watch in the 21st Century by Advertising Age in 1999.